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IntroductionThe World Health Organization ranks liver cancer among the 
five cancers with the highest death rate in the world [1]. Currently, 
in the treatment of this disease are practiced, for example, 
resection of hepatic tissue and radiofrequency ablation, a non-
invasive method. Although the resection presents the best results, 
only 10% to 15% of those affected by this disease can perform 
this procedure [2]. For radiofrequency ablation (RFA), which consists of the burning of the tumor tissue from the passage of 
high current density, treatment occurs in cases of primary hepatic 
carcinoma with a diameter of up to 3 cm. The radiofrequency ablation process acts by causing local cell necrosis to reach a 
temperature above 60°C and below 100°C [3,4]. The RFA presents advantageous aspects such it does not require the hospitalization 
of the patient and anesthesia. However, it is necessary to improve fundamental points to increase the effectiveness of this 
procedure [5]. As a main point, one can cite the minimization of the attribution of the success of the procedure to the skill and / 
or experience of the clinical professional of the same, providing 
parameters (eg tissue temperature, applied power and tissue 
impedance) from the radiofrequency equipment itself, optimizing the actuation protocol and the use of imaging equipment used 
to guide the insertion of the electrode for ablation. In addition, other points such as the uniformity and increase of the volume of 
ablation are also of high relevance in this field of study.
Great progress was achieved in this area with the introduction 
of modified electrodes and saline solutions in the ablation 
region, which allowed a significant increase in necrosis volume 
using a single electrode [6]. Other advances were also obtained 
in the monitoring and analysis of the RFA procedure, with the 
application of fiber optic sensors to perform the online monitoring 
of the temperature in the region of ablation [7]. The temperature analysis is able to quantify the heat distribution in the ablation 
region and thereby determine the efficiency of the procedure 
performed [8]. In this work, the next section will discuss the 
challenges and proposals for some of the complexities to be 
overcome in the ablation by RFA, followed by a brief conclusion on the subject by the authors of this article.  
Discussion 
Necrosis volumes limited to 3 cm can be explained by factors 
related to RFA. Current generators can be used with powers 
between 50W and 200W with control algorithms that include 
temperature or impedance in the tissue region. However, studies 
show that power is not the only determining factor in obtaining 
larger volumes [9].  Temperature or impedance control allows 
better results and can be optimized. Control algorithms that use temperature as a parameter must include losses due to blood perfusion that acts as a heat sink minimizing the effects 
of temperature propagation [10]. This temperature should be guaranteed throughout the tumor volume to avoid recurrence in regions that did not reach this temperature. The possibility of 
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Abstract
The World Health Organization classifies liver cancer among the five types of cancer 
with highest death rates in the world. Among the current methods available for the 
treatment of liver cancer, there is the resection of hepatic tissue and the radiofrequency 
ablation of the tumor. Even though resection presents the best results, only 10% 
to 15% of the affected patients may eligible for this procedure. On the other hand, the radiofrequency ablation encompasses a larger scope of patients and provides a 
non-invasive method when compared to resection. There is research with sufficient 
evidence to allow the transposition of this concept to new technological paradigms, 
which would yield a more effective ablation process, i.e.: generating enough volumetric 
necrosis for complete regression of the tumor, leading to a high survival rate of 
patients. These technological paradigms encompass aspects of operability, innovation 
and of theoretical framework. In terms of operability, there is the use of better imaging 
sources to aid the healthcare professional in the positioning of electrodes; in terms of 
innovation, there are new technologies such as the use of optical fiber microsensors 
and metallic magnetic nanoparticles to increase the efficiency of the process; in terms 
of theoretical framework, there is the development of more precise mathematical 
models that would expand the possibilities of application and increase its effectiveness. 
These new challenges are new possibilities that may reshape the concept and the use 
of radiofrequency ablation as it is currently known.
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reducing the size of the sensors and circuits using, for example, 
MEMS (Micro-Electro Mechanical Systems) type components 
consisting of integrated devices in the order of a few micrometers 
up to a few millimeters may comprise a complete microelectronic 
system with microsensor and microactuators [11]. The use of 
MEMS would allow the insertion of microcomponents into the 
actual volume of the tumor. Thus, parameters such as point 
temperature, impedance and positioning of the electrode can be 
acquired more accurately and give greater accuracy to the power control algorithms of the ablation equipment and the adequacy of the electrode geometry to the area of necrosis. 
Also in the application of technologies with microcomponents, it is possible to propose a microsystem for the insertion of 
fluids in the tissue during the ablation process. The fluids 
can act to accelerate the ablation process (greater volume of 
burning in less time) or to cool the ablation site (delay the 
arrival at the carbonization temperature). In the work of Evans 
et al. [12], a mixed microsystem for drug infusion is proposed 
in patients with chronic pain, using two pressurized chambers 
with springs controlled by two independent micro valves and a 
microcontroller, regulating the flow and presenting satisfactory 
efficiency In the delivery of the fluid. Despite the application in 
another focus of Biomedical Engineering, the method is useful as an initial understanding for use during the radiofrequency 
ablation process. In the field of nanobiotechnology, the use of metallic magnetic nanoparticles to induce local hyperthermia in tumor tissues through radiofrequency interaction has been 
shown to be a potentially more effective therapeutic option by improving the transfer of temperature in the ablation area and in 
a controlled manner [13]. The use of chemotherapeutic agents, 
such as gemcitabine, conjugated to gold nanoparticles during ablation by radiofrequency in cases of hepatocellular carcinoma 
allows to reduce the dose and to apply it locally eliminating some disadvantages of its systemic application in the patient during its 
recovery [14]. Increased necrosis area has been demonstrated 
with the association of iron oxide (FeO) nanoparticles in cases of cardiac arrhythmia due to changes in thermal and electrical 
conductivity caused by large changes in tissue impedance [15]. 
Finally, the perspectives are increasing considering the advance 
of the lines of research with nanoparticles as propeller of the 
benefits of the use of RFA. 
Conclusion The paradigm that involves the state of the art of RFA induces 
the continuity of research in view of the various advantages of 
RFA such as low invasiveness, hospitalization and anesthesia 
unnecessary, as well as a good survival to its patients. There 
is research with sufficient evidence to redirect this concept 
to the new technological projections that will make it more 
effective in its ablation process, generating enough volumetric necrosis for complete regression of the tumor added to a high survival rate. In addition to the adjustments already in progress to use better images to guide the health professional during 
electrode positioning and combined use with other therapies, 
new technologies such as microsensors and microactuators, magnetic metallic nanoparticles and more mathematical models 
which can possibility of RFA in the treatment of tumor nodules 
and the increase of its effectiveness. The new challenges present themselves as possibilities and reshape the concept of the use of RFA already established. 
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